Ebola Outbreak in Congo Surpasses Historical Records
The ongoing Ebola outbreak in Congo is poised to surpass the deadliest outbreak in history, which claimed over 11,000 lives, according to the World Health Organization’s director, Tedros Adhanom Ghebreyesus.
He noted, “At its current pace, it’s on track to eclipse the West African Ebola outbreak of 2014 to 2016.” That previous outbreak left a significant mark on global health initiatives, particularly accelerating vaccine development.
The situation in eastern Congo, labeled as the fastest-growing Ebola outbreak ever, has already resulted in over 2,000 fatalities from more than 4,300 reported cases. Although it was officially declared on May 15, genetic sequencing suggests the outbreak started much earlier, in February.
This outbreak is particularly troubling because the causative agent, a rare Bundibugyo virus, lacks approved treatments or vaccines, although work is currently underway to address this gap.
Challenges in Managing the Outbreak
Experts indicate that this outbreak is advancing quicker than the response efforts, especially in remote areas of eastern Congo dealing with ongoing conflict near borders with South Sudan, Uganda, and Rwanda.
Many new cases and deaths are occurring in communities where healthcare workers have limited access due to poor infrastructure. Some health workers have even initiated strikes over unpaid wages. Misinformation abounds, creating hesitancy among locals, some of whom are reluctant to visit clinics.
“The outbreak had a big head start, still way ahead of us, and we’re playing catch-up,” Tedros remarked.
Dr. Abdirahman Mahamud from the WHO stated that they anticipate reaching the peak of this outbreak within the next six months.
However, he added, “But… that’s the moderate scenario. There’s a more dire possibility where this outbreak might extend nine to twelve months.” This current outbreak has already surpassed previous ones, including the 2014-2016 outbreak, with a faster death rate and fewer cases logged in the same timeframe.
Vaccine Development Underway
Ebola is infrequent yet highly transmissible, capable of spreading through bodily fluids like blood or vomit, as well as contaminated surfaces. The disease is severe and often lethal.
Recently, clinical trials for two potential treatments specifically targeting this strain of Ebola commenced in Ituri, the most affected province.
Two vaccines developed for the Bundibugyo virus are currently being tested on human subjects for the first time, according to Tedros. Additionally, the WHO plans to investigate whether an existing Ebola vaccine could offer cross-protection, showing optimism based on promising initial animal studies.
Researchers are gaining clarity regarding the outbreak’s origins. A recent study published in Nature Medicine reinforces the idea that the outbreak likely originated from a transmission event between animals and humans, rather than being connected to past outbreaks. The genetic analysis indicates differences from viruses identified in earlier Bundibugyo outbreaks.
